19 December 2018 - Deborah Wilkes
Premium
Japan's Taisho Pharmaceutical is set to acquire Bristol-Myers Squibb's French consumer healthcare business UPSA for USD1.6 billion.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.